
LATEST APPEARANCES










Combining the power of psychedelics and neuroscience for mental health, personal transformation, and optimal functioning.
I’m a neuroscientist and biotech founder working at the intersection of psychedelic science, neuroplasticity, and translational medicine. As Co-Founder & CEO of Five Discovery, I lead a pre-seed biotech developing next-generation neuroplastogens for neurodegenerative disease — psychedelic-inspired compounds re-engineered for neurological benefit without the psychedelic experience. I also serve as Scientific Director of The Center for MINDS, a nonprofit advancing research into psychedelics as catalysts for creativity and insight.
My scientific foundation is grounded in a PhD in neuroscience from McGill University and a postdoctoral fellowship under Robin Carhart-Harris at UCSF. I have published over two dozen peer-reviewed papers spanning psychedelic science, cognitive neuroscience, and related topics, including in journals such as Nature Medicine, Proceedings of the National Academy of Sciences, Brain, and Trends in Cognitive Sciences.
Whether you’re a researcher, investor, psychonaut, or just curious about where psychedelic science is heading, I hope you find something of value here.
Five Discovery is a regenerative neurology biotech developing non-hallucinogenic serotonergic compounds to restore and stabilize dysfunctional neural circuits underlying neurodegenerative disease.
© 2024 Manesh Girn | All Rights Reserved | A Responsible Initiative
© 2024 Manesh Girn | All Rights Reserved | A Responsible Initiative